MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, RYTM has $506,874K in assets. $211,191K in debts. $52,078K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
474.55%
Quick Ratio
453.35%
Cash Ratio
49.95%
Debt to Asset Ratio
41.67%
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Series a convertible preferred s...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
52,078 135,586
Short-term investments
363,974 155,444
Accounts receivable, net
33,034 26,122
Inventory
22,107 18,872
Prepaid expenses and other current assets
23,609 24,656
Total current assets
494,802 360,680
Property and equipment, net
237 297
Right-of-use asset
3,158 3,262
Intangible assets, net
5,533 5,747
Restricted cash
671 527
Other long-term assets
2,473 2,220
Total assets
506,874 372,733
Accounts payable
13,631 15,982
Accrued expenses and other current liabilities
84,456 69,185
Other current liability - lg chem
-40,000
Lease liability
624 510
Deferred royalty obligation, current
5,556 3,778
Total current liabilities
104,267 129,455
Deferred royalty obligation
103,409 106,014
Lease liability, non-current
3,515 3,681
Total liabilities
211,191 239,150
Series a convertible preferred stock, 0.001 par value 150,000 shares authorized 150,000 and 150,000 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively. liquidation preference of 150,000 as of september 30, 2025
146,866 145,491
Common stock, 0.001 par value 120,000,000 shares authorized 66,684,077 and 62,390,654 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
67 64
Additional paid-in capital
1,454,048 1,241,744
Accumulated other comprehensive (loss)
-926 -2,248
Accumulated deficit
-1,304,372 -1,251,468
Total stockholders' equity
148,817 -11,908
Total liabilities, convertible preferred stock and stockholders' equity
506,874 372,733
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$23,609K Inventory$22,107K Accounts receivable, net$33,034K Short-term investments$363,974K Cash and cashequivalents$52,078K Other long-termassets$2,473K Restricted cash$671K Intangible assets, net$5,533K Right-of-use asset$3,158K Property and equipment,net$237K Total current assets$494,802K Total assets$506,874K Total liabilities,convertible preferred stock...$506,874K Total stockholders'equity$148,817K Series a convertiblepreferred stock, 0.001 par...$146,866K Total liabilities$211,191K Accumulated deficit-$1,304,372K Accumulated othercomprehensive (loss)-$926K Additional paid-in capital$1,454,048K Lease liability,non-current$3,515K Deferred royaltyobligation$103,409K Total currentliabilities$104,267K Common stock, 0.001 parvalue 120,000,000...$67K Deferred royaltyobligation, current$5,556K Lease liability$624K Accrued expenses andother current...$84,456K Accounts payable$13,631K

RHYTHM PHARMACEUTICALS, INC. (RYTM)

RHYTHM PHARMACEUTICALS, INC. (RYTM)